Mei Wei, MD, an oncologist specializing in breast cancer at Huntsman Cancer Institute at the University of Utah, discusses new treatments for HR+/HER2- breast cancer and immunotherapy challenges, ...

In a real-world diverse population of patients with early triple-negative breast cancer (TNBC), 34% of patients who received ...

Maternal hidradenitis suppurativa was linked to an increased risk for pregnancy complications and long-term adverse outcomes in mothers and children.

In a response to a survey, caregivers of people with spinal muscular atrophy identified the risk of severe adverse events and ...

Beam Therapeutics' early clinical data shows promising results for sickle cell disease treatment using CRISPR gene editing tool. One patient died ...

BEAM-101 seems to be competitive with approved sickle cell treatments, William Blair analysts said in a note to investors, ...

Q3 2024 Earnings Call Transcript November 4, 2024 Supernus Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is ...

Anavex Life Sciences' (AVXL) stock surged on new Alzheimer's trial data, but data's inconsistency raises concerns, making the ...

Dried blood spot testing is a less invasive alternative to traditional blood draws for monitoring service member toxic ...

(RTTNews) - Arcus Biosciences, Inc. (RCUS), Tuesday announced results from part 1 of ARC-10, evaluating the effects of the combination of Domvanalimab and Zimberelimab versus Zimberelimab or ...

The English High Court has held that a geotechnical event ("GE") at a mine in Brazil did not engage the material adverse effect ("MAE") clause in ...

Although polycythemia vera management remains focused on reducing the risk of thrombotic events, there is growing recognition ...